Stay updated with breaking news from Package Leaflet. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GAITHERSBURG, Md., Sept. 27, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious
Standard marketing authorization recommendation applies to all indications and formulations in the European Union, including COMIRNATY Original/Omicron BA.4-5 and COMIRNATY Original/Omicron BA.1 bivalent
Investegate announcements from BioNTech SE, Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional Marketing Authorization to Full Marketing Authorization in the European Union
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
The Israeli Advisory Committee on Epidemics has recommended that Nuvaxovid be approved for ages 12 and older as a primary series and as a heterologous booster for those previously vaccinated